IL10 rs3024492: Dust Mite Allergy Risk & Gene Expression
The rs3024492 polymorphism is a regulatory single nucleotide variant located in the promoter region of the interleukin-10 (IL10) gene. Scientific studies associate this variant with differences in baseline IL-10 cytokine production and an altered risk of allergic sensitization, particularly in response to domestic dust mite exposure. Because these associations depend heavily on environmental exposure and show variable effect sizes across populations, the overall clinical evidence remains limited.
What each genotype means
Typical IL10 expression
This genotype represents the most common form of this variant in many populations. Research suggests that individuals with this profile may have a different baseline for interleukin-10 regulation compared to those carrying the minor allele, though clinical significance remains limited and context-dependent.
This is the most frequent genotype observed across European and East Asian cohorts.
Intermediate IL10 expression
Carrying one copy of the minor allele may result in intermediate levels of interleukin-10 expression. The functional impact of this genotype is highly dependent on environmental factors, such as exposure to dust mite allergens, which may modify the risk of allergic sensitization.
This heterozygous genotype is commonly found in diverse populations, appearing in a significant portion of the general public.
Altered IL10 expression
Homozygosity for the minor allele has been associated in some studies with increased IgE levels and a higher risk of asthma exacerbations, specifically in the presence of high dust mite allergen exposure. This association is considered limited and may not apply to all individuals or environments; please discuss any respiratory concerns with your healthcare provider.
This genotype is less common than the CC or CT genotypes, occurring at lower frequencies across European and East Asian populations.
Genetic Location and Nature of rs3024492
The single nucleotide polymorphism rs3024492 represents a single-base variation located on chromosome 1 within the regulatory promoter region upstream of the IL10 gene. Classified as a non-coding regulatory variant, it does not alter the amino acid sequence of the final protein. Instead, variants within the upstream promoter sequence can modify binding affinity for nuclear transcription factors, subtly tuning how much mRNA transcription takes place. Databases like dbSNP record this variation as an A/T polymorphism (often reported along the minus or plus genomic strand depending on the reference build). Because promoter elements act as the primary rheostat for immune signaling, sequence alterations in this flanking region can exert subtle but measurable physiological shifts in cellular responsiveness.
Biological Role of the IL10 Gene
The IL10 gene encodes interleukin-10, an essential anti-inflammatory cytokine produced primarily by monocytes, macrophages, and regulatory T cells (Tregs). Interleukin-10 plays a critical role in preserving immune homeostasis by dampening exaggerated inflammatory cascades, inhibiting pro-inflammatory cytokine synthesis, and limiting tissue damage during infection or environmental challenge. In the context of allergic disease, adequate IL-10 production is crucial for inducing tolerance to benign airborne particles such as house dust mite allergens. When regulatory pathways underperform or produce lower quantities of IL-10, helper T-cell responses (specifically Th2 pathways) can become hyperactive, leading to higher immunoglobulin E (IgE) synthesis and mucosal allergic sensitization.
Published Research and Evidence Quality
Current scientific literature identifies rs3024492 as a candidate marker for immune regulation, allergic rhinitis, and asthma-related phenotypes. Most notably, candidate gene and gene-environment interaction studies have demonstrated that domestic dust mite allergen exposure significantly modifies the relationship between rs3024492 genotypes and allergic sensitization. In cohorts evaluated for environmental triggers, homozygosity for the minor allele was correlated with an elevated risk of high specific IgE titers and allergic exacerbations in high-exposure households. However, broad genome-wide association studies (GWAS) often show modest or non-significant population-wide effect sizes when environmental exposure is unmeasured. Because these findings stem largely from targeted candidate studies and depend on exposure interactions, the scientific evidence supporting rs3024492 as a standalone predictor is currently classified as limited.
Population Distribution and Allele Diversity
According to population databases such as gnomAD and the 1000 Genomes Project, rs3024492 is a common polymorphism found globally, although allele frequencies vary by ancestry. In European and East Asian cohorts, the minor allele generally circulates at low-to-moderate frequencies (global minor allele frequency roughly 10% to 15%), making heterozygous and homozygous carriers relatively frequent in general populations. Other global populations, including Admixed American and African cohorts, display varying baselines of this variant. This common distribution emphasizes that the minor allele is a natural, widespread element of human immune diversity rather than a rare pathogenic mutation.
Clinical Interpretation and Practical Application
Direct-to-consumer genetic test results showing rs3024492 provide educational context regarding baseline immune regulation but cannot diagnose allergic rhinitis, asthma, or any other clinical condition. Common genetic variants account for only a tiny fraction of individual allergy risk, which is predominantly shaped by cumulative environmental exposures, overall lifestyle, and the combined effects of hundreds of other genes. Carrying an allele associated with altered IL-10 expression does not guarantee an allergy, nor does a standard genotype guarantee protection. Anyone experiencing symptoms of chronic congestion, wheezing, or suspected allergic reactions should consult an allergist or immunologist for formal diagnostic evaluations such as skin-prick testing or serum allergen-specific IgE quantification.
How common is this variant?
The rs3024492 variant is a common polymorphism across global populations, with the minor allele present at approximately 10% to 15% frequency in European and East Asian cohorts.
Frequently asked questions
Does having the rs3024492 variant mean I have a dust mite allergy?
No, carrying this variant does not mean you have or will develop a dust mite allergy. The SNP is only associated with relative statistical changes in immune reactivity, and allergies require complex interactions between many genes and physical environmental exposures.
Can rs3024492 guide allergy medications or treatments?
No clinical guidelines recommend altering allergy treatments, antihistamines, or asthma medications based on rs3024492 genotype. Medical management should be directed by licensed healthcare professionals based on confirmed clinical symptoms and allergy testing.
Why is the IL10 gene important in allergies?
The IL10 gene produces interleukin-10, an anti-inflammatory cytokine that calms the immune system and promotes tolerance to harmless substances. Variations that affect IL-10 levels can alter how aggressively the immune system reacts when breathing in common allergens.
What role does indoor environment play with this variant?
Scientific studies show that the risk associated with rs3024492 is modified by environmental allergen concentrations. In homes with very low dust mite counts, the variant often shows minimal to no detectable impact on allergy risk.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3024492?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL10
Regulatory upstream noncoding variant in IL10 that influences anti-inflammatory cytokine production.
The -592C/A variant in the promoter of IL-10 regulates transcription factor binding, impacting cytokine output and risk for inflammatory bowel disease.
The IL-10 promoter -819C/T polymorphism modulates interleukin-10 expression, influencing inflammatory responses and autoimmune susceptibility.
Part of the extended IL-10 promoter haplotype influencing differential anti-inflammatory IL-10 cytokine output and susceptibility to graft-versus-host disease.
Functional promoter variant (-1082 A/G) influencing interleukin-10 expression levels and inflammatory disease susceptibility.
Variant in the interleukin-10 gene interacting with environmental dust mite exposure to significantly alter the risk of allergic sensitization and exacerbations.